312 related articles for article (PubMed ID: 34399795)
21. Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer: a multi-institutional study.
O'Loughlin M; Andreu X; Bianchi S; Chemielik E; Cordoba A; Cserni G; Figueiredo P; Floris G; Foschini MP; Heikkilä P; Kulka J; Liepniece-Karele I; Regitnig P; Reiner A; Ryska A; Sapino A; Shalaby A; Stovgaard ES; Quinn C; Walsh EM; Zolota V; Glynn SA; Callagy G
Breast Cancer Res Treat; 2018 Aug; 171(1):1-9. PubMed ID: 29774470
[TBL] [Abstract][Full Text] [Related]
22. [Prediction of Response to Neoadjuvant Chemotherapy for Breast Cancer Based on Histomorphology Analysis of Needle Biopsy Images].
Xu CY; Xie JW; Yang CX; Jiang YN; Zhang ZH; Xu J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 52(2):279-285. PubMed ID: 33829703
[TBL] [Abstract][Full Text] [Related]
23. Multi-input deep learning architecture for predicting breast tumor response to chemotherapy using quantitative MR images.
El Adoui M; Drisis S; Benjelloun M
Int J Comput Assist Radiol Surg; 2020 Sep; 15(9):1491-1500. PubMed ID: 32556920
[TBL] [Abstract][Full Text] [Related]
24. A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients.
Hwang HW; Jung H; Hyeon J; Park YH; Ahn JS; Im YH; Nam SJ; Kim SW; Lee JE; Yu JH; Lee SK; Choi M; Cho SY; Cho EY
Breast Cancer Res Treat; 2019 Jan; 173(2):255-266. PubMed ID: 30324273
[TBL] [Abstract][Full Text] [Related]
25. Interobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association with pathological complete response: the IVITA study.
Van Bockstal MR; François A; Altinay S; Arnould L; Balkenhol M; Broeckx G; Burguès O; Colpaert C; Dedeurwaerdere F; Dessauvagie B; Duwel V; Floris G; Fox S; Gerosa C; Hastir D; Jaffer S; Kurpershoek E; Lacroix-Triki M; Laka A; Lambein K; MacGrogan GM; Marchiò C; Martin Martinez MD; Nofech-Mozes S; Peeters D; Ravarino A; Reisenbichler E; Resetkova E; Sanati S; Schelfhout AM; Schelfhout V; Shaaban A; Sinke R; Stanciu-Pop CM; van Deurzen CHM; Van de Vijver KK; Van Rompuy AS; Vincent-Salomon A; Wen HY; Wong S; Bouzin C; Galant C
Mod Pathol; 2021 Dec; 34(12):2130-2140. PubMed ID: 34218258
[TBL] [Abstract][Full Text] [Related]
26. Predicting neoadjuvant chemotherapy benefit using deep learning from stromal histology in breast cancer.
Li F; Yang Y; Wei Y; Zhao Y; Fu J; Xiao X; Zheng Z; Bu H
NPJ Breast Cancer; 2022 Nov; 8(1):124. PubMed ID: 36418332
[TBL] [Abstract][Full Text] [Related]
27. The effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes in patients with breast cancer.
Ilgun AS; Aktepe F; Gonullu O; Kapucuoglu N; Yararbas K; Alco G; Ozturk A; Elbuken Celebi F; Erdogan Z; Ordu C; Unal C; Duymaz T; Soybir G; Yavuz E; Tuzlali S; Ozmen V
Future Oncol; 2022 Sep; 18(29):3289-3298. PubMed ID: 36017739
[TBL] [Abstract][Full Text] [Related]
28. Pretreatment ultrasound-based deep learning radiomics model for the early prediction of pathologic response to neoadjuvant chemotherapy in breast cancer.
Yu FH; Miao SM; Li CY; Hang J; Deng J; Ye XH; Liu Y
Eur Radiol; 2023 Aug; 33(8):5634-5644. PubMed ID: 36976336
[TBL] [Abstract][Full Text] [Related]
29. Multimodal deep learning models for the prediction of pathologic response to neoadjuvant chemotherapy in breast cancer.
Joo S; Ko ES; Kwon S; Jeon E; Jung H; Kim JY; Chung MJ; Im YH
Sci Rep; 2021 Sep; 11(1):18800. PubMed ID: 34552163
[TBL] [Abstract][Full Text] [Related]
30. Deep Learning of Multimodal Ultrasound: Stratifying the Response to Neoadjuvant Chemotherapy in Breast Cancer Before Treatment.
Gu J; Zhong X; Fang C; Lou W; Fu P; Woodruff HC; Wang B; Jiang T; Lambin P
Oncologist; 2024 Feb; 29(2):e187-e197. PubMed ID: 37669223
[TBL] [Abstract][Full Text] [Related]
31. Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer.
Ono M; Tsuda H; Shimizu C; Yamamoto S; Shibata T; Yamamoto H; Hirata T; Yonemori K; Ando M; Tamura K; Katsumata N; Kinoshita T; Takiguchi Y; Tanzawa H; Fujiwara Y
Breast Cancer Res Treat; 2012 Apr; 132(3):793-805. PubMed ID: 21562709
[TBL] [Abstract][Full Text] [Related]
32. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.
Denkert C; von Minckwitz G; Darb-Esfahani S; Lederer B; Heppner BI; Weber KE; Budczies J; Huober J; Klauschen F; Furlanetto J; Schmitt WD; Blohmer JU; Karn T; Pfitzner BM; Kümmel S; Engels K; Schneeweiss A; Hartmann A; Noske A; Fasching PA; Jackisch C; van Mackelenbergh M; Sinn P; Schem C; Hanusch C; Untch M; Loibl S
Lancet Oncol; 2018 Jan; 19(1):40-50. PubMed ID: 29233559
[TBL] [Abstract][Full Text] [Related]
33. Digital image analysis and machine learning-assisted prediction of neoadjuvant chemotherapy response in triple-negative breast cancer.
Fisher TB; Saini G; Ts R; Krishnamurthy J; Bhattarai S; Callagy G; Webber M; Janssen EAM; Kong J; Aneja R
Res Sq; 2023 Aug; ():. PubMed ID: 37645881
[TBL] [Abstract][Full Text] [Related]
34. Biomarkers Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.
Li XB; Krishnamurti U; Bhattarai S; Klimov S; Reid MD; O'Regan R; Aneja R
Am J Clin Pathol; 2016 Jun; 145(6):871-8. PubMed ID: 27298399
[TBL] [Abstract][Full Text] [Related]
35. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
36. Deep learning radiomics of ultrasonography can predict response to neoadjuvant chemotherapy in breast cancer at an early stage of treatment: a prospective study.
Gu J; Tong T; He C; Xu M; Yang X; Tian J; Jiang T; Wang K
Eur Radiol; 2022 Mar; 32(3):2099-2109. PubMed ID: 34654965
[TBL] [Abstract][Full Text] [Related]
37. Early prediction of neoadjuvant chemotherapy response for advanced breast cancer using PET/MRI image deep learning.
Choi JH; Kim HA; Kim W; Lim I; Lee I; Byun BH; Noh WC; Seong MK; Lee SS; Kim BI; Choi CW; Lim SM; Woo SK
Sci Rep; 2020 Dec; 10(1):21149. PubMed ID: 33273490
[TBL] [Abstract][Full Text] [Related]
38. Effect of breast cancer phenotype on diagnostic performance of MRI in the prediction to response to neoadjuvant treatment.
Bufi E; Belli P; Di Matteo M; Terribile D; Franceschini G; Nardone L; Petrone G; Bonomo L
Eur J Radiol; 2014 Sep; 83(9):1631-8. PubMed ID: 24938669
[TBL] [Abstract][Full Text] [Related]
39. A spatial attention guided deep learning system for prediction of pathological complete response using breast cancer histopathology images.
Duanmu H; Bhattarai S; Li H; Shi Z; Wang F; Teodoro G; Gogineni K; Subhedar P; Kiraz U; Janssen EAM; Aneja R; Kong J
Bioinformatics; 2022 Sep; 38(19):4605-4612. PubMed ID: 35962988
[TBL] [Abstract][Full Text] [Related]
40. [The application of 3-dimensional shear wave elastography in the therapeutic effect evaluation of neoadjuvant chemotherapy for Her-2 positive breast cancer patients].
Ma BX; Fan ZN; Wu G
Zhonghua Zhong Liu Za Zhi; 2020 Dec; 42(12):1049-1054. PubMed ID: 33342163
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
